Medicine
Navitrux 150 mg/5 mL powder for injection
Navitrux 150 mg/5 mL powder for injection is a prescription medicine containing Fosaprepitant for intravenous use, marketed by Avyxa Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
NAVITRUX vials must be refrigerated, store at 2°C to 8°C (36°F to 46°F). The…
Key facts
- Active ingredient (INN)
- Fosaprepitant
- Brand
- Navitrux
- Strength
- 150 mg/5 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Avyxa Pharma
- Manufacturer
- Avyxa Pharma
- Origin register
- US FDA, United States
- Storage
- NAVITRUX vials must be refrigerated, store at 2°C to 8°C (36°F to 46°F). The total storage time of reconstituted NAVITRUX and diluted solutions should not exceed 24 hours at ambient room temperature
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD12 Fosaprepitant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 July 2026
- Identifiers
- RxCUI 1731077, 2745874DailyMed set ID a41b7c3a-1376-43a7-b5b9-6ba2eba1e169NDC 83831-153Application NDA220436
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 5 mL in 1 vial | 83831-153-01 | AVYXA Pharma | 23 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fosaprepitant 150 mg/5 mL powder for injection.
Other strengths and forms of Fosaprepitant
Clinical summary
Fosaprepitant is a substance P/neurokinin-1 receptor antagonist. It is available as powder for injection and injection for intravenous use. MedsAcross supplies Fosaprepitant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FosaprepitantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMEND prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Ivemend: European public assessment report (EPAR) · European Medicines Agency
Need Navitrux 150 mg/5 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.